VRDN Latest Headlines

Truist Financial Sticks to Their Buy Rating for Viridian Therapeutics (VRDN)

at www.tipranks.com (Fri, 27-Feb 7:59 AM)

Analysts Offer Insights on Healthcare Companies: Novavax (NVAX), DENTSPLY SIRONA (XRAY) and Viridian Therapeutics (VRDN)

at www.tipranks.com (Fri, 27-Feb 7:20 AM)

Viridian’s Accelerating Pipeline and $875M Cash Position Set Up for Key 2026 Milestones

Market Chameleon (Thu, 26-Feb 7:39 AM)

Analysts Offer Insights on Healthcare Companies: Crescent Biopharma (CBIO) and Viridian Therapeutics (VRDN)

at www.tipranks.com (Thu, 26-Feb 4:50 PM)

Analysts’ Top Healthcare Picks: Heron Therapeutics (HRTX), Viridian Therapeutics (VRDN)

at www.tipranks.com (Thu, 26-Feb 1:20 PM)

Analysts Are Bullish on Top Healthcare Stocks: Delcath Systems (DCTH), Viridian Therapeutics (VRDN)

at www.tipranks.com (Thu, 26-Feb 11:30 AM)

Viridian Therapeutics misses Q4 estimates

at seekingalpha.com (Thu, 26-Feb 7:45 AM)

Strategic Buy on Viridian Therapeutics Ahead of Veligrotug PDUFA and Elegrobart Phase 3 REVEAL-1 Readout

at www.tipranks.com (Tue, 24-Feb 12:05 PM)

Viridian Grants 16,650 Inducement Options as Pipeline Progresses in Thyroid Eye Disease

Market Chameleon (Fri, 9-Jan 9:40 AM)

Viridian’s Veligrotug Advances with FDA Priority Review—Pivotal Data Shows Robust, Rapid Results for Thyroid Eye Disease

Market Chameleon (Mon, 22-Dec 11:17 AM)